Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
In commentary of Leukemia Consciousness Month in September, CURE spoke with an professional about fundamentals of the illness.In commentary of Leukemia Consciousness Month...
Sufferers can finest advocate for themselves by asking questions, staying knowledgeable, and remembering they've the proper to be energetic contributors of their care,...
Dr. Paul Gellhaus, urologic oncologist and medical director of robotic surgical procedure at Metropolis of Hope Most cancers Heart Phoenix, emphasizes that worry...
